Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modification of Disease Outcome in COPD
NCT00158847Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone and salmeterol in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Leiden University Medical Center. Primary endpoint: Localisation, numbers and profile of inflammatory cells in bronchial biopsy specimens at 2.5 years. Started Apr 2000; status: terminated.
02
Drugs
fluticasonesalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00158847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158847.